NCT06619314View on ClinicalTrials.gov

A Study to Evaluate the Effect of Food, Formulation, and a Proton Pump Inhibitor (PPI) on MK-1084 in Healthy Adult Participants (MK-1084-003)

PHASE1CompletedINTERVENTIONAL

Enrollment

56

Participants

Timeline

Start Date

September 20, 2023

Primary Completion Date

November 25, 2023

Study Completion Date

November 25, 2023

Conditions

Healthy

Interventions

DRUG

MK-1084

Oral Tablet

DRUG

PPI

Oral Capsule

Trial Locations (1)

68502

Celerion (Site 0001), Lincoln

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY